Mevion Medical Systems competitors

Michael Tardugno is a President and Chief Executive Officer at CELSION CORP and is based in United States.

Joined Varian as an intern in 1999, then full time in 2001, and has held multiple cross-functional roles and executive positions during two-decade tenure with the company. Intimate understanding of healthcare, software solutions, medical devices, technology trends, reimbursement trends and strategies that lead to success in targeted channel segments globally. Marketing strategy, new product launch, portfolio strategy, M&A, P&L, restructuring, government relations, and general management experience. Consistent creation of strategies and execution against operating plans, sales goals and market objectives, including extensive experience of both high growth and slow growth periods (turnaround plans) of Varian Medical Systems journey from $500M to over $3B. Including returning Varian to double digit growth following becoming President of the $3B+ P&L of Oncology systems. Strong leadership skills with a track record of creating an inspiring vision and communicating effectively both internally/externally through developing cultural, servant leadership and focusing on people/teams to drive net promoter scores to all-time highs and enable sustainable long-term success.

Matthew Call is a Chief Executive Officer at Photomedex.

Prior to founding ABT in 2006, Dr. Nutt co-founded CTI Molecular Imaging, Inc. in 1983. He was Vice President of Research and Development from 1983 through 1998 when he became the President of CTI PET Systems, a joint venture between Siemens and CTI. In 2002 he became the President and Chief Executive Officer of CTI Molecular Imaging, Inc. a NASDAQ public company. Dr. Nutt led the negotiations resulting in the sale of CTI to Siemens in 2005. As Vice President of R&D, Dr. Nutt had more than 30 patents in the field of molecular imaging, authored and co-authored a large number of technical publications and has presented invited talks at numerous conferences. Prior to founding CTI Molecular Imaging, Dr. Nutt was the co-founder of several other companies including Technology for Energy Corporation, Radio Systems Corporation and Delta M Corporation. Dr. Nutt was the Vice President of EG&G ORTEC during the time frame of 1969 through 1979 where he was responsible for developing many innovations in the field of nuclear physics instrumentation. Prior to ORTEC he was a researcher at the Oak Ridge National Laboratory and taught Electrical Engineering at the University of Tennessee. Dr. Nutt holds a BS, MS and PhD from the University of Tennessee and was awarded in 1997 the Dean Daugherty award for his outstanding achievements, the highest Engineering Alumni honors. Dr. Nutt is a Fellow of the IEEE and was named by the organization the Outstanding Engineering for the Eastern part of the US in 1999 for his contributions to molecular imaging. He was also awarded the Distinguished Scientist of the Year by the Academy of Molecular Imaging in year 1999.

Jon Slater is a Chief Executive Officer at OPTIVUS PROTON THERAPY INC and is based in Loma Linda, California. He studied at University of Utah between 1981 and 1985.